[PDF][PDF] Treatment of hepatitis C virus–associated mixed cryoglobulinemia with direct‐acting antiviral agents
ME Sise, AK Bloom, J Wisocky, MV Lin… - …, 2016 - Wiley Online Library
Hepatitis C virus (HCV) is the most common cause of mixed cryoglobulinemia syndrome
(MCS). The efficacy and safety of all‐oral direct‐acting antiviral (DAA) therapy in HCV …
(MCS). The efficacy and safety of all‐oral direct‐acting antiviral (DAA) therapy in HCV …
Treatment of hepatitis C virus–associated mixed cryoglobulinemia with direct‐acting antiviral agents
ME Sise, AK Bloom, J Wisocky, MV Lin, JL Gustafson… - Hepatology, 2016 - journals.lww.com
Hepatitis C virus (HCV) is the most common cause of mixed cryoglobulinemia syndrome
(MCS). The efficacy and safety of all‐oral direct‐acting antiviral (DAA) therapy in HCV …
(MCS). The efficacy and safety of all‐oral direct‐acting antiviral (DAA) therapy in HCV …
Treatment of hepatitis C virus–associated mixed cryoglobulinemia with direct‐acting antiviral agents
ME Sise, AK Bloom, J Wisocky, MV Lin, JL Gustafson… - Hepatology, 2015 - cir.nii.ac.jp
抄録< jats: p> Hepatitis C virus (HCV) is the most common cause of mixed cryoglobulinemia
syndrome (MCS). The efficacy and safety of all‐oral direct‐acting antiviral (DAA) therapy in …
syndrome (MCS). The efficacy and safety of all‐oral direct‐acting antiviral (DAA) therapy in …
[PDF][PDF] Treatment of Hepatitis C Virus-Associated Mixed Cryoglobulinemia with Sofosbuvir-Based Direct-Acting Antiviral Agents
ME Sise, AK Bloom, J Wisocky, MV Lin, JL Gustafson… - Hepatology, 2016 - academia.edu
Abstract Background—Hepatitis C virus (HCV) is the most common cause of mixed
cryoglobulinemia syndrome (MCS). The efficacy and safety of all-oral directly-acting antiviral …
cryoglobulinemia syndrome (MCS). The efficacy and safety of all-oral directly-acting antiviral …
Treatment of hepatitis C virus–associated mixed cryoglobulinemia with direct‐acting antiviral agents
ME Sise, AK Bloom, J Wisocky, MV Lin, JL Gustafson… - Hepatology, 2016 - infona.pl
Hepatitis C virus (HCV) is the most common cause of mixed cryoglobulinemia syndrome
(MCS). The efficacy and safety of all‐oral direct‐acting antiviral (DAA) therapy in HCV …
(MCS). The efficacy and safety of all‐oral direct‐acting antiviral (DAA) therapy in HCV …
Treatment of hepatitis C virus-associated mixed cryoglobulinemia with direct-acting antiviral agents.
ME Sise, AK Bloom, J Wisocky, MV Lin, JL Gustafson… - 2016 - cabidigitallibrary.org
Hepatitis C virus (HCV) is the most common cause of mixed cryoglobulinemia syndrome
(MCS). The efficacy and safety of all-oral direct-acting antiviral (DAA) therapy in HCV …
(MCS). The efficacy and safety of all-oral direct-acting antiviral (DAA) therapy in HCV …
Treatment of hepatitis C virus-associated mixed cryoglobulinemia with direct-acting antiviral agents.
ME Sise, AK Bloom, J Wisocky, MV Lin… - Hepatology …, 2015 - europepmc.org
Conclusion SVR12 rates for sofosbuvir-based DAA regimens in HCV-MCS were 83%,
significantly higher than historical controls treated with pegylated interferon and ribavirin; …
significantly higher than historical controls treated with pegylated interferon and ribavirin; …
[HTML][HTML] Treatment of Hepatitis C Virus-Associated Mixed Cryoglobulinemia with Sofosbuvir-Based Direct-Acting Antiviral Agents
ME Sise, AK Bloom, J Wisocky, MV Lin… - Hepatology …, 2016 - ncbi.nlm.nih.gov
Background Hepatitis C virus (HCV) is the most common cause of mixed cryoglobulinemia
syndrome (MCS). The efficacy and safety of all-oral directly-acting antiviral (DAA) therapy in …
syndrome (MCS). The efficacy and safety of all-oral directly-acting antiviral (DAA) therapy in …
Treatment of hepatitis C virus-associated mixed cryoglobulinemia with direct-acting antiviral agents
ME Sise, AK Bloom, J Wisocky… - Hepatology …, 2016 - pubmed.ncbi.nlm.nih.gov
Hepatitis C virus (HCV) is the most common cause of mixed cryoglobulinemia syndrome
(MCS). The efficacy and safety of all-oral direct-acting antiviral (DAA) therapy in HCV …
(MCS). The efficacy and safety of all-oral direct-acting antiviral (DAA) therapy in HCV …
Treatment of hepatitis C virus–associated mixed cryoglobulinemia with direct-acting antiviral agents
ME Sise, AK Bloom, J Wisocky, MV Lin, JL Gustafson… - Hepatology, 2016 - eemh.gr
Στην παρούσα εργασία οι συγγραφείς μελέτησαν σειρά ασθενών με μικτή κρυοσφαιριναιμία
στο πλαίσιο χρόνιας HCV λοίμωξης, οι οποίοι έλαβαν σχήματα με βάση το sofosbuvir και …
στο πλαίσιο χρόνιας HCV λοίμωξης, οι οποίοι έλαβαν σχήματα με βάση το sofosbuvir και …